| Stimulation of nuclear receptor peroxisome proliferator–activated receptor‐γ limits NF‐κB‐dependent inflammation in mouse cystic fibrosis biliary epithelium R Scirpo, R Fiorotto, A Villani, M Amenduni, C Spirli, M Strazzabosco Hepatology 62 (5), 1551-1562, 2015 | 120 | 2015 |
| The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity R Fiorotto, A Villani, A Kourtidis, R Scirpo, M Amenduni, PJ Geibel, ... Hepatology 64 (6), 2118-2134, 2016 | 66 | 2016 |
| Clearance by microglia depends on packaging of phagosomes into a unique cellular compartment A Villani, J Benjaminsen, C Moritz, K Henke, J Hartmann, N Norlin, ... Developmental cell 49 (1), 77-88. e7, 2019 | 52 | 2019 |
| Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease C Spirli, V Mariotti, A Villani, L Fabris, R Fiorotto, M Strazzabosco Journal of hepatology 66 (3), 571-580, 2017 | 39 | 2017 |
| A role for the centrosome in regulating the rate of neuronal efferocytosis by microglia in vivo K Möller, M Brambach, A Villani, E Gallo, D Gilmour, F Peri Elife 11, e82094, 2022 | 11 | 2022 |
| Microglia: Picky brain eaters A Villani, F Peri Developmental cell 48 (1), 3-4, 2019 | 3 | 2019 |
| Rapid unleashing of macrophage efferocytic capacity via transcriptional pause release T Tufan, G Comertpay, A Villani, GM Nelson, M Terekhova, S Kelley, ... Nature, 1-8, 2024 | | 2024 |
| In vivo analysis of neuronal clearance by microglia uncovers a new compartment in the phagocytic pathway A Villani EMBL - Heidelberg University, 2018 | | 2018 |
| Osteogenesi Imperfetta A Villani | | 2014 |
| CFTR controls a membrane multi-protein complex that regulates c-Src tyrosine kinase activity and TLR4 signaling in cholangiocytes: implication of cystic fibrosis liver disease … A Villani Università Milano-Bicocca, 2013 | | 2013 |
| Mutazioni nel gene PPIB (Ciclofilina B) associate all'Osteogenesi Imperfetta A Villani Università Milano-Bicocca, 2011 | | 2011 |
Carlo SpirliAssociate Professor of Medicine, Yale UniversityVerified email at yale.edu
